STAT· @statnews · X·· 7 小时前AI 评分38
AI 导读
随着远程医疗公司Hims & Hers和Noom本周推出相关产品,肽类即将走向主流,两家公司均宣布将为符合条件的患者提供处方。
正文
Peptides are poised to go mainstream with this week’s launches from telehealth companies Hims & Hers and Noom, both of which announced they will be offering prescriptions for eligible patients. https://www.statnews.com/2026/11/19/hims-noom-enter-peptide-market-mainstream-products-health-risks/
来源:STAT · x.com